BRANDI GOWIN: Open Payments
NPI 1780102293 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,646 in 154 payments from 21 companies in 2025. Trend: 2023 $1,776 · 2024 $1,718 · 2025 $2,646
Food & beverage: $2,616Education: $30
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $670 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $330 |
| Janssen Biotech, Inc. | 14 | $278 |
| Phathom Pharmaceuticals, Inc. | 22 | $269 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $226 |
| Gilead Sciences, Inc. | 8 | $187 |
| GENZYME CORPORATION | 9 | $167 |
| Ipsen Biopharmaceuticals, Inc | 6 | $98 |
| Ardelyx, Inc. | 3 | $66 |
| Madrigal Pharmaceuticals | 2 | $65 |
Products named: XIFAXAN, RINVOQ, TREMFYA, VOQUEZNA, DUPIXENT, ENTYVIO, LINZESS, SKYRIZI.
Industry payments across KY — which companies pay providers there.
